Editor of Patient Care Online.
Obesity and Venous Disease: Expert Details Optimal Treatment Options
Shagun Bindlish, MD, board member of the American Diabetes Association, details available options for treating venous disease in patients with obesity.
New COVID-19 Vaccination Guidance for Older Adults & High-Risk Groups: A Conversation with NFID Medical Director Robert Hopkins, Jr, MD
Guidance from the Advisory Committee on Immunization Practices on best practices for COVID-19 vaccination continues to evolve, Hopkins explained.
USPSTF Issues Final Recommendations on Osteoporosis Screening to Prevent Fractures
The USPSTF recommends all women ages 65 and older and at-risk postmenopausal women under 65 should be screened for osteoporosis.
Elinzanetant VMS Update: As Positive Results Pile Up, Bayer Readies for Menopause Treatment’s Future
FDA action date set for July 26, 2025.
Higher Daily Step Count Linked to Lower Risk for Depression: Daily Dose
Your daily dose of the clinical news you may have missed.
Early Hypertensive Screening in Patients with Obesity: Expert Perspective
Obesity medicine expert Caissa Troutman, MD, suggests using annual physicals as a "gateway" to identify patients with obesity with elevated blood pressure.
Minimal Distress Reported with Multi-Cancer Early Detection Testing: New Findings from PATHFINDER Trial
A new analysis of patient reported outcomes from the PATHFINDER study indicate the potential clinical benefit of early cancer detection.
CRC Screening Expansion Strains Community Health Centers: Daily Dose
Non-Hormonal Therapy for Menopausal VMS: How Does Elinzanetant Differ from HRT?
JoAnn Pinkerton, MD, national lead for the OASIS clinical trial program evaluating elinzanetant for menopausal VMS, discusses how non-hormonal therapy differs from HRT.
Understanding the Obesity-Hypertension Connection: A Clinician Discussion
Caissa Troutman, MD, provides an overview of the connection between obesity and hypertension.
Phase 1b Trial of Oligomer-Targeting Agent PMN310 for Alzheimer Disease Gets Underway
The study will assess the safety, tolerability, and pharmacokinetics of PMN310 in individuals with mild cognitive impairment or early-stage AD.
Women Show Higher Genetic Predisposition to PTSD: Daily Dose
The Biggest Challenge with COVID-19 Right Now: An Interview with NFID Medical Director Robert Hopkins, Jr, MD
Hopkins, of the National Foundation for Infectious Diseases, is frustrated by the diminished societal response to the virus' circulation including ongoing low vaccination rates.
Managing Hypertension in Patients with Obesity: Clinician Strategies for Long-Term Care
Caissa Troutman, MD, an obesity medicine and family medicine physician, emphasizes early treatment of obesity, along with HTN management, can improve patient outcomes.
Orexo Announces Positive Topline Data for Nasal Epinephrine Powder OX640 in People with Allergic Rhinitis
Treatments with the investigational rescue medication achieved clinically effective epinephrine levels faster than intramuscular injection.
Viking Therapeutics Launches Phase 2 Trial for Oral VK2735 in Patients with Obesity
The trial builds on results from a previous phase 1 study that showed dose-dependent weight loss and favorable tolerability for VK2735 in people with obesity.
Mobile App Shows Promise for Hypertension Management: Daily Dose
Menopausal Vasomotor Symptoms: Clinician and Patients Both Need Education, Expert Says
Less than 15% of women in menopause receive treatment for VMS, suggesting a need a for more education and awareness, according to JoAnn Pinkerton, MD.
FDA Updates RSV Vaccine Labels to Include Guillain-Barré Syndrome Warning
The FDA approved the addition of Guillain-Barré syndrome warnings for Abrysvo and Arexvy, citing postmarketing data suggesting an increased risk.
FDA OKs Tapinarof Cream, 1% for Atopic Dermatitis In Patients Aged 2 Years and Older: Daily Dose
American College of Gastroenterology Releases Updated Guidelines for Eosinophilic Esophagitis
The updated guidelines include 19 recommendations related to the diagnosis and management of eosinophilic esophagitis.
Prenatal Antibiotic Exposure Linked to Childhood Health Issues: Daily Dose
Sanofi and SK Bioscience Expand Pneumococcal Vaccine Partnership, Launch Phase 3 Trial for PCV21
Sanofi and SK bioscience expand collaboration on pneumococcal conjugate vaccines, including a 21-valent candidate for pediatric populations.
Pivotal Obesity Trials in 2024: A Conversation with Donna Ryan, MD
Donna Ryan, MD, discusses the most significant clinical trials published this year in the field of obesity medicine.
Mediterranean Diet Ranked Best Diet Overall for 8th Consecutive Year
The 2025 rankings released by U.S. News & World Report featured 13 new diets and 12 new categories.
Menopausal VMS Education in Primary Care: Build Trust First, Says One Clinician
Building trust with patients early on will help them feel comfortable discussing their symptoms and treatment preferences, says JoAnn Pinkerton, MD.
FDA Greenlights New Treatment for Moderate-to-Severe Atopic Dermatitis: Daily Dose
Vaccination Information and Educational Resources from the National Foundation for Infectious Diseases
Robert Hopkins, Jr, MD, NFID medical director, details a range of resources on the foundation's website including in-depth vaccine recommendations, live webinars, plus much more.
New Data Suggest Revised Colorectal Cancer Screening Guidelines Strain Community Health Centers
The USPSTF's revised CRC screening guidelines to include adults aged 45-49 years increased screening needs by about 23% without additional funding or resources for CHCs.
Emerging Obesity Research to Watch For in 2025
Donna Ryan, MD, highlights exciting advancements in weight loss and metabolic treatments, particularly involving GLP-1 RAs and related therapies.
